Interaction of positively-charged liposomes with blood: implications for their application in vivo.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Biochimica et Biophysica Acta

• Publication date

  1991-11-18

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0005-2736(91)90160-APMID 1751523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A comparative study on the antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin given as a bolus, continuous infusion or entrapped in liposomes in the Lou/M Wsl rat

  2004cited by this paper
• Protection of Toxoplasma gondii-infected mice by stearylamine-bearing liposomes.

  1990cited by this paper
• Liposomes in vivo: prospects for liposome-based pharmaceuticals in the 1990s.

  1990cited by this paper
• A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin.

  1990cited by this paper
• Pharmacokinetic and pharmacodynamic evaluation of liposomal cyclosporine

  1989cited by this paper
• A radiolabel and electron microscopy study of the interaction of liposomes with synaptosomal membranes.

  1989cited by this paper
• Treatment of Brucella melitensis infection in mice by use of liposome-encapsulated gentamicin.

  1989cited by this paper
• Effect of positive charge of liposomes on their clearance from the blood and its relation to vesicle lipid composition

  1989cited by this paper
• Successful treatment with liposomal amphotericin B in two patients with persisting fungemia

  1989cited by this paper
• Fate and behavior of liposomes in vivo: a review of controlling factors.

  1987cited by this paper
• Cytolytic activity of liposomes containing stearylamine.

  1986cited by this paper
• Lysis of human red blood cells in the presence of various cosolvents.

  1985cited by this paper
• Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection.

  1985cited by this paper
• Liposome-entrapped diethylstilbestrol effect on prostate gland and plasma testosterone levels in rats.

  1984cited by this paper
• Doxorubicin-induced chronic cardiotoxicity and its protection by liposomal administration.

  1982cited by this paper
• Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components.

  1982cited by this paper
• Inhibition of cationic liposomes of [3H]thymidine incorporation into DNA of L1210 cells.

  1981cited by this paper
• Effects of oral administration of positively charged insulin liposomes on alloxan diabetic rats: preliminary study.

  1979cited by this paper
• Liposome toxicity in the mouse central nervous system.

  1977cited by this paper
• Lipid vesicle-cell interactions. I. Hemagglutination and hemolysis

  1976cited by this paper
• Interaction of liposomes with blood plasma proteins.

  1976cited by this paper

• Involvement of Non-Coding RNAs in the Glucose Metabolic Reprogramming of Oral Squamous Cell Carcinoma: From Mechanisms to Therapeutics

  2026cites this paper
• Targeted Delivery of Erlotinib via Hyaluronic Acid-Conjugated PEGylated Liposomes for Enhanced Efficacy in A549 Lung Cancer Cells

  2025cites this paper
• Systemic toxicity and toxicokinetics study of self-assembled-micelle inhibitory RNA-targeting amphiregulin in cynomolgus monkeys following intravenous injection

  2025cites this paper
• Hybrid nano-scaffolds loaded with resveratrol and Omega-3 fatty Acids: An innovative antimicrobial strategy against biofilm.

  2025cites this paper
• Liposome-mediated gene delivery: A comprehensive review of biophysical parameters, lipid composition and targeting strategies

  2025cites this paper
• PEGylation Enhances Colloidal Stability and Promotes Ligand-Mediated Targeting of LAF–Xenopeptide mRNA Complexes

  2025cites this paper
• The secret life of RNA and lipids

  2025cites this paper
• Lipid nanoparticles: a promising tool for nucleic acid delivery in cancer immunotherapy

  2025cites this paper
• Recent Advances in Lipid Nanoparticles: Nucleic Acid Therapeutics and Targeting Strategies.

  2025cites this paper
• In Vitro Comparative Study on Oppositely Charged Donepezil-Loaded Intranasal Liposomes

  2025cites this paper
• Permanently Charged Cationic Lipids—Evolution from Excipients to Therapeutic Lipids

  2024cites this paper
• Effects of excipients on the interactions of self-emulsifying drug delivery systems with human blood plasma and plasma membranes

  2024cites this paper
• Inhalable GSH-Triggered Nanoparticles to Treat Commensal Bacterial Infection in In Situ Lung Tumors.

  2023cites this paper
• Positively charged and neutral drug-loaded liposomes as the aerosolized formulations for the efficacy assessment of tumor metastases to lungs

  2022cites this paper
• Development of lipid nanoparticles and liposomes reference materials (II): cytotoxic profiles

  2022cites this paper
• Multi-Dose Intravenous Administration of Neutral and Cationic Liposomes in Mice: An Extensive Toxicity Study

  2022influential citation
• Mineralizing Gelatin Microparticles as Cell Carrier and Drug Delivery System for siRNA for Bone Tissue Engineering

  2022cites this paper
• Factors affecting the pharmacokinetics of the liposomal drugs

  2021cites this paper
• Tailoring drug and gene codelivery nanosystems for glioblastoma treatment

  2021cites this paper
• Cubosomes: Novel Nanocarriers for Drug Delivery

  2021cites this paper
• Fate of Biomaterials Post Payload Delivery: Current Understanding and Future Perspectives

  2021cites this paper
• Systemic gene delivery using lipid envelope systems and its potential in overcoming challenges

  2021cites this paper
• Gene Therapy

  2021cites this paper
• The current landscape of nucleic acid therapeutics

  2021cites this paper
• Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems

  2021cites this paper
• Lipoplex-based therapeutics for effective oligonucleotide delivery: a compendious review

  2020cites this paper
• A systematic study on chitosan-liposome based systems for biomedical applications.

  2020cites this paper
• Environment‐Responsive Lipid/siRNA Nanoparticles for Cancer Therapy

  2020cites this paper
• Zeta potential changing nanoemulsions: Impact of PEG-corona on phosphate cleavage.

  2020cites this paper
• In vivo fate of liposomes after subconjunctival ocular delivery.

  2020cites this paper
• Optimization of Chitosan-α-casein Nanoparticles for Improved Gene Delivery: Characterization, Stability, and Transfection Efficiency

  2019cites this paper
• Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy.

  2019cites this paper
• Evaluating the therapeutic efficacy of Grb2 inhibition in ovarian malignancies

  2019cites this paper
• Development of Afatinib lipid nanoparticles targeting non small cell lung cancer

  2018cites this paper
• Amino acid-based liposomal assemblies : Intracellular plasmid DNA delivery nanoparticles

  2018cites this paper
• Non-viral Gene Delivery.

  2018cites this paper
• Effect of Liposome Treatment on Hemorheology and Metabolic Profile of Human Red Blood Cells During Hypothermic Storage

  2018cites this paper
• Cationic liposomes induce cytotoxicity in HepG2 via regulation of lipid metabolism based on whole-transcriptome sequencing analysis

  2018cites this paper
• Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design

  2018cites this paper
• The Effects of Liposome Treatment on Red Blood Cells during Hypothermic Storage

  2017cites this paper
• Cationic nanoemulsions as nucleic acids delivery systems.

  2017cites this paper
• Effect of Composition and Method of Preparation of Liposomes on Their Stability and lnteraction with Murine Monocytes. lnfected with Brucella abortus

  2017cites this paper
• Liposomal delivery of PDE5 inhibitors and UT-15C to human erythrocytes

  2016cites this paper
• Unfolding the Hsp90 Foldasome: Structure-Activity Relationship Studies on EGCG and Development of Isoform-Selective Inhibitors

  2016cites this paper
• Fluctuations et interactions en situation de nano-confinement anisotrope

  2016cites this paper
• Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come

  2016cites this paper
• Application of Liposomes in Biopreservation

  2016cites this paper
• Liposomes as nanomedical devices

  2015cites this paper
• Lipid- and polymer-based drug delivery carriers for eradicating microbial biofilms causing medical device-related infections.

  2015cites this paper
• Systemic drug delivery systems for bone tissue regeneration- a mini review.

  2015cites this paper
• Biofilm-based Healthcare-associated Infections

  2015cites this paper
• Liposomes and Lipid Envelope-Type Systems for Systemic siRNA Delivery.

  2015cites this paper
• Non-viral nanocarriers for siRNA delivery in breast cancer.

  2014cites this paper
• Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.

  2014cites this paper
• Adsorption of antisense oligonucleotides targeting malarial topoisomerase II on cationic nanoemulsions optimized by a full factorial design.

  2014cites this paper
• Nanomedicine: de novo design of nanodrugs.

  2014cites this paper
• Dextran-peptide hybrid for efficient gene delivery.

  2014cites this paper
• Application of Pharmacokinetic and Pharmacodynamic Analysis to the Development of Liposomal Formulations for Oncology

  2014cites this paper
• Overcoming biological barriers to nanomedicines for the treatment of pulmonary biofilm infections in cystic fibrosis

  2014cites this paper
• Multifunctional Natural Material-based Delivery Systems for Gene Therapy

  2014cites this paper
• Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo.

  2013cites this paper
• Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells.

  2013cites this paper
• Lipid nanoparticles encapsulating siRNAs against the androgen receptor to treat advanced prostate cancer

  2013cites this paper
• RGD-conjugated Nanoparticles for Targeted Inhibition of Metastasis of Integrin αvβ3-overexpressing Breast Cancer Cells

  2013cites this paper
• Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems

  2012cites this paper
• Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment.

  2012cites this paper
• Therapeutic siRNAs and nonviral systems for their delivery

  2012cites this paper
• Pharmacogenomics-based RNA interference nanodelivery: focus on solid malignant tumors

  2012cites this paper
• Conception et évaluation d'un vecteur ciblé de thérapie génique anticancéreuse destiné à la voie intraveineuse

  2012cites this paper
• “Wrapped Up” Vaccines in the Context of HIV-1 Immunotherapy

  2012cites this paper
• Efficient and safe delivery of siRNA using anionic lipids: Formulation optimization studies.

  2012cites this paper
• Multimodal nanoparticles for quantitative imaging

  2011cites this paper
• Grand challenges in modulating the immune response with RNAi nanomedicines.

  2011cites this paper
• Treating metastatic cancer with nanotechnology

  2011cites this paper
• Cationic nanoemulsion as a delivery system for oligonucleotides targeting malarial topoisomerase II.

  2011cites this paper
• Nano anti-cancer drugs: pros and cons and future perspectives.

  2011cites this paper
• Liposome-encapsulated midazolam for oral administration

  2011cites this paper
• Influence of phospholipid composition on cationic emulsions/DNA complexes: physicochemical properties, cytotoxicity, and transfection on Hep G2 cells

  2011cites this paper
• Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes

  2010cites this paper
• Liposomes as Drug Delivery Carriers to Biofilms

  2010cites this paper
• Emerging role of vesicular carriers for therapy of visceral leishmaniasis: conventional versus novel.

  2010cites this paper
• Bolaamphiphiles based novel liposomes: a possible approach for drug delivery

  2010cites this paper
• Nanoparticle-based delivery system for application of siRNA in vivo.

  2010cites this paper
• Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides.

  2009cites this paper
• In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation.

  2008cites this paper
• The potential of lipid- and polymer-based drug delivery carriers for eradicating biofilm consortia on device-related nosocomial infections.

  2008cites this paper
• Evaluation of the toxicity of oligonucleotide/cationic nanoemulsion complexes on Hep G2 cells through MTT assay.

  2008cites this paper
• Optimization of stearylamine-based nanoemulsions obtained by spontaneous emulsification process as nucleic acids delivery systems

  2008cites this paper
• 8 – Lipid self-assembled particles for the delivery of nutraceuticals

  2008cites this paper
• Extraction and quantification of the cationic lipid 1,2-dioleoyl-3-trimethylammonium propane from human plasma.

  2007cites this paper
• Effect of Liposome Characteristics and Dose on the Pharmacokinetics of Liposomes Coated with Poly(amino acid)s

  2007cites this paper
• Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.

  2007cites this paper
• Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections

  2007cites this paper
• Toxicity of cationic lipids and cationic polymers in gene delivery.

  2006cites this paper
• Designing Cell- and Gene-Based Regeneration Strategies To Repair the Injured Spinal Cord

  2006cites this paper
• Mechanistic studies of sequential injection of cationic liposome and plasmid DNA.

  2006cites this paper
• Role of Cholesterol, DOTAP, and DPPC in Prostasome/Spermatozoa Interaction and Fusion

  2006cites this paper
• Gene delivery using cationic liposomes

  2006cites this paper
• Studies of factors influencing drug efflux rates from liposomes and their impact on antitumor efficacy

  2006cites this paper
• Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity.

  2005cites this paper